CF Industries Holding, Inc.
CFNYSECIK 1324404Basic Materials / Chemicalsfiscal year ends December73 quarters since 2008
Latest quarter Q2 FY2026, filed August 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q3 FY2022 to Q2 FY2026, through the filing of August 6, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.
| Millions of dollars | Q2 FY2026ended Jun 30, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 31, 2026filed May 7, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025 | Q1 FY2025ended Mar 31, 2025filed May 8, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025 | Q3 FY2024ended Sep 30, 2024filed Oct 31, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,222 | 1,986 | 1,872 | 1,659 | 1,890 | 1,663 | 1,524 | 1,370 | +17.6% |
| Cost of revenue | 1,077 | 1,240 | 1,107 | 1,027 | 1,135 | 1,091 | 1,000 | 926 | −5.1% |
| Gross profit | 1,145 | 746 | 765 | 632 | 755 | 572 | 524 | 444 | +51.7% |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 89 | 103 | 91 | 88 | 101 | 84 | 78 | 78 | −11.9% |
| Operating income | 1,121 | 863 | 617 | 580 | 648 | 455 | 441 | 364 | +73.0% |
| Other income (expense) | (4) | 0 | 8 | 3 | 6 | 2 | 6 | 4 | −166.7% |
| Pretax income | 1,093 | 844 | 602 | 565 | 635 | 437 | 433 | 400 | +72.1% |
| Income tax | 224 | 168 | 107 | 105 | 143 | 86 | 41 | 59 | +56.6% |
| Net income | — | — | — | — | — | — | — | — | — |
| Diluted EPS ($) | 4.73 | 3.98 | — | 2.19 | 2.37 | 1.85 | — | 1.55 | +99.6% |
| Diluted shares (millions) | 154 | 155 | — | 161 | 163 | 169 | — | 179 | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.
| Millions of dollars | Q2 FY2026ended Jun 30, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 31, 2026filed May 7, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025 | Q1 FY2025ended Mar 31, 2025filed May 8, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025 | Q3 FY2024ended Sep 30, 2024filed Oct 31, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | — | — | — | — | — | — | — |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 3,752 | 3,391 | 2,985 | 2,978 | 2,676 | 2,433 | 2,520 | 2,850 | +40.2% |
| Total assets | 15,099 | 14,608 | 14,088 | 14,203 | 13,750 | 13,308 | 13,466 | 13,843 | +9.8% |
| Total current liabilities | 772 | 958 | 887 | 1,310 | 830 | 939 | 818 | 1,013 | −7.0% |
| Long-term debt | 3,216 | 3,216 | 3,215 | 2,974 | 2,973 | 2,972 | 2,971 | 2,970 | +8.2% |
| Total liabilities | — | — | — | — | — | — | — | — | — |
| Stockholders’ equity | 5,748 | 5,342 | 4,838 | 4,849 | 4,963 | 4,780 | 4,985 | 5,194 | +15.8% |
| Shares outstanding (millions) | 151 | 154 | 154 | 156 | 162 | 162 | 170 | 174 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.
| Millions of dollars | Q2 FY2026ended Jun 30, 2026filed Aug 6, 2026 | Q1 FY2026ended Mar 31, 2026filed May 7, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 25, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025 | Q1 FY2025ended Mar 31, 2025filed May 8, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 20, 2025 | Q3 FY2024ended Sep 30, 2024filed Oct 31, 2024 | YoYQ2 FY2026vs Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 878 | 496 | 539 | 1,064 | 563 | 586 | 420 | 931 | +56.0% |
| Capital expenditures | 271 | 223 | 226 | 347 | 245 | 132 | 197 | 139 | +10.6% |
| Free cash flow (CFO − capex) | 607 | 273 | 313 | 717 | 318 | 454 | 223 | 792 | +90.9% |
| Depreciation and amortization | 215 | 228 | 228 | 217 | 232 | 221 | 221 | 229 | −7.3% |
| Share repurchases | 225 | 28 | 345 | 360 | 216 | 444 | 375 | 490 | +4.2% |
| Dividends paid | 77 | 78 | 78 | 81 | 81 | 86 | 86 | 90 | −4.9% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 25, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 25, 2026 | FY2024ended Dec 31, 2024filed Feb 20, 2025 | FY2023ended Dec 31, 2023filed Feb 22, 2024 | FY2022ended Dec 31, 2022filed Feb 23, 2023 | FY2021ended Dec 31, 2021filed Feb 24, 2022 | FY2020ended Dec 31, 2020filed Feb 24, 2021 | FY2019ended Dec 31, 2019filed Feb 24, 2020 | FY2018ended Dec 31, 2018filed Feb 22, 2019 | FY2017ended Dec 31, 2017filed Feb 22, 2018 | FY2016ended Dec 31, 2016filed Feb 23, 2017 | FY2015ended Dec 31, 2015filed Feb 25, 2016 | FY2014ended Dec 31, 2014filed Feb 26, 2015 | FY2013ended Dec 31, 2013filed Feb 27, 2014 | FY2012ended Dec 31, 2012filed Feb 27, 2013 | FY2011ended Dec 31, 2011filed Feb 27, 2012 | FY2010ended Dec 31, 2010filed Feb 25, 2011 | FY2009ended Dec 31, 2009filed Feb 25, 2010 | FY2008ended Dec 31, 2008filed Aug 3, 2009 | FY2007ended Dec 31, 2007filed Aug 3, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,084 | 5,936 | 6,631 | 11,186 | 6,538 | 4,124 | 4,590 | 4,429 | 4,130 | 3,685 | 4,308 | 4,743 | 5,475 | 6,104 | 6,098 | 3,965 | 2,608 | 3,921 | 2,757 |
| Cost of revenue | 4,360 | 3,880 | 4,086 | 5,325 | 4,151 | 3,323 | 3,416 | 3,512 | 3,696 | 2,842 | — | — | — | — | — | — | — | — | — |
| Gross profit | 2,724 | 2,056 | 2,545 | 5,861 | 2,387 | 801 | 1,174 | 917 | 434 | 843 | 1,547 | 1,778 | 2,520 | 3,113 | 2,896 | 1,180 | 839 | 1,223 | 670 |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 364 | 320 | 289 | 290 | 223 | 206 | 239 | 214 | 191 | 173 | 170 | 152 | 166 | 152 | 130 | 106 | 63 | 68 | 65 |
| Operating income | 2,300 | 1,746 | 2,230 | 5,397 | 1,729 | 623 | 1,003 | 766 | 234 | 138 | 1,193 | 2,366 | 2,412 | 2,959 | 2,791 | 896 | 680 | 1,150 | 602 |
| Other income (expense) | 19 | 14 | 10 | (15) | 16 | 1 | 7 | 9 | 3 | (2) | (4) | (2) | (54) | 1 | 1 | 29 | 13 | 1 | 2 |
| Pretax income | 2,239 | 1,762 | 2,248 | 5,095 | 1,543 | 463 | 772 | 547 | (125) | (226) | 1,058 | 2,187 | 2,210 | 2,830 | 2,646 | 688 | 696 | 1,175 | 626 |
| Income tax | 441 | 285 | 410 | 1,158 | 283 | 31 | 126 | 119 | (575) | (68) | 396 | 773 | 687 | 964 | 927 | 274 | 246 | 378 | 200 |
| Net income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1,539 | 349 | 366 | 685 | 373 |
| Diluted EPS ($) | 8.97 | 6.74 | 7.87 | 16.38 | 4.24 | 1.47 | 2.23 | 1.24 | 1.53 | (1.19) | 2.96 | 5.42 | 4.95 | 5.72* | 4.40* | 1.07* | 1.48* | 2.43* | 1.31* |
| Diluted shares (millions) | 162 | 181 | 194 | 204 | 216 | 215 | 222 | 234 | 234 | 233 | 236 | 257 | 296 | 324* | 350* | 327* | 246* | 282* | 284* |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 25, 2026 | FY2024ended Dec 31, 2024filed Feb 20, 2025 | FY2023ended Dec 31, 2023filed Feb 22, 2024 | FY2022ended Dec 31, 2022filed Feb 23, 2023 | FY2021ended Dec 31, 2021filed Feb 24, 2022 | FY2020ended Dec 31, 2020filed Feb 24, 2021 | FY2019ended Dec 31, 2019filed Feb 24, 2020 | FY2018ended Dec 31, 2018filed Feb 22, 2019 | FY2017ended Dec 31, 2017filed Feb 22, 2018 | FY2016ended Dec 31, 2016filed Feb 23, 2017 | FY2015ended Dec 31, 2015filed Feb 25, 2016 | FY2014ended Dec 31, 2014filed Feb 26, 2015 | FY2013ended Dec 31, 2013filed Feb 27, 2014 | FY2012ended Dec 31, 2012filed Feb 27, 2013 | FY2011ended Dec 31, 2011filed Feb 27, 2012 | FY2010ended Dec 31, 2010filed Feb 25, 2011 | FY2009ended Dec 31, 2009filed Feb 25, 2010 | FY2008ended Dec 31, 2008filed Aug 3, 2009 | FY2007ended Dec 31, 2007filed Aug 3, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | — | — | — | — | 287 | 682 | 835 | 1,169 | 309 | 1,997 | 1,711 | 2,275 | 1,207 | 798 | 697 | 625 | 367 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3 | 185 | — | — |
| Total current assets | 2,985 | 2,520 | 3,050 | 3,673 | 2,593 | 1,367 | 974 | 1,274 | 1,465 | 2,655 | 1,127 | 2,531 | 2,630 | 2,808 | 1,799 | 1,341 | 1,283 | 1,433 | — |
| Total assets | 14,088 | 13,466 | 14,376 | 13,313 | 12,375 | 12,023 | 12,172 | 12,661 | 13,463 | 15,131 | 12,683 | 11,254 | 10,678 | 10,167 | 8,975 | 8,754 | 2,495 | 2,388 | — |
| Total current liabilities | 887 | 818 | 800 | 995 | 1,432 | 906 | 665 | 705 | 580 | 686 | 1,215 | 980 | 828 | 950 | 1,031 | 949 | 480 | 818 | — |
| Long-term debt | 3,215 | 2,971 | 2,968 | 2,965 | 3,465 | 3,712 | 3,957 | 4,698 | 4,692 | 5,778 | 5,537 | 4,593 | 3,098 | 1,600 | 1,613 | 1,954 | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stockholders’ equity | 4,838 | 4,985 | 5,717 | 5,051 | 3,206 | 2,922 | 2,897 | 2,958 | 3,579 | 3,348 | 4,035 | 4,210 | 5,076 | 5,902 | 4,547 | 4,050 | 1,729 | 1,338 | — |
| Shares outstanding (millions) | 154 | 170 | 188 | 196 | 207 | 214 | 216 | 223 | 233 | 233 | 233 | 240* | 277* | 315* | 327* | 356* | 243* | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 25, 2026 | FY2024ended Dec 31, 2024filed Feb 20, 2025 | FY2023ended Dec 31, 2023filed Feb 22, 2024 | FY2022ended Dec 31, 2022filed Feb 23, 2023 | FY2021ended Dec 31, 2021filed Feb 24, 2022 | FY2020ended Dec 31, 2020filed Feb 24, 2021 | FY2019ended Dec 31, 2019filed Feb 24, 2020 | FY2018ended Dec 31, 2018filed Feb 22, 2019 | FY2017ended Dec 31, 2017filed Feb 22, 2018 | FY2016ended Dec 31, 2016filed Feb 23, 2017 | FY2015ended Dec 31, 2015filed Feb 25, 2016 | FY2014ended Dec 31, 2014filed Feb 26, 2015 | FY2013ended Dec 31, 2013filed Feb 27, 2014 | FY2012ended Dec 31, 2012filed Feb 27, 2013 | FY2011ended Dec 31, 2011filed Feb 27, 2012 | FY2010ended Dec 31, 2010filed Feb 25, 2011 | FY2009ended Dec 31, 2009filed Feb 25, 2010 | FY2008ended Dec 31, 2008filed Aug 3, 2009 | FY2007ended Dec 31, 2007filed Aug 3, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2,752 | 2,271 | 2,757 | 3,855 | 2,873 | 1,231 | 1,505 | 1,497 | 1,631 | 617 | 1,207 | 1,421 | — | — | — | 1,194 | 682 | 639 | 690 |
| Capital expenditures | 950 | 518 | 499 | 453 | 514 | 309 | 404 | 422 | 473 | 2,211 | 2,469 | 1,809 | 824 | 524 | 247 | 258 | 236 | 142 | 105 |
| Free cash flow (CFO − capex) | 1,802 | 1,753 | 2,258 | 3,402 | 2,359 | 922 | 1,101 | 1,075 | 1,158 | (1,594) | (1,262) | (388) | — | — | — | 936 | 446 | 497 | 585 |
| Depreciation and amortization | 898 | 925 | 869 | 850 | 888 | 892 | 875 | 888 | 883 | 678 | 480 | 393 | 411 | 420 | 416 | 395 | 101 | 101 | 85 |
| Share repurchases | 1,365 | 1,509 | 580 | 1,347 | 539 | 100 | 370 | 467 | 0 | 0 | 556 | 1,935 | 1,409 | 500 | 1,000 | — | — | 500 | — |
| Dividends paid | 326 | 364 | 311 | 306 | 260 | 258 | 265 | 280 | 280 | 280 | 282 | 256 | 129 | 103 | 69 | 26 | 19 | 22 | 5 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | Scribner Andrew | EVP and CFO | award | 6,464 | $0.00 | — | 6,464 | May 28, 2026 |
| Apr 28, 2026 | DeHaas Deborah L | Director | award | 1,390 | $0.00 | — | 12,233 | Apr 30, 2026 |
| Apr 28, 2026 | Wagler Theresa E | Director | award | 1,390 | $0.00 | — | 36,464 | Apr 30, 2026 |
| Apr 28, 2026 | Eaves John W | Director | award | 1,390 | $0.00 | — | 27,336 | Apr 30, 2026 |
| Apr 28, 2026 | Ellerbusch Susan A | Director | award | 1,390 | $0.00 | — | 7,323 | Apr 30, 2026 |
| Apr 28, 2026 | Madrazo Yris Jesus | Director | award | 1,390 | $0.00 | — | 12,473 | Apr 30, 2026 |
| Apr 28, 2026 | Noonan Anne P | Director | award | 2,208 | $0.00 | — | 34,870 | Apr 30, 2026 |
| Apr 28, 2026 | Toelle Michael | Director | award | 1,390 | $0.00 | — | 27,336 | Apr 30, 2026 |
| Apr 28, 2026 | White Celso L. | Director | award | 1,390 | $0.00 | — | 23,429 | Apr 30, 2026 |
| Apr 28, 2026 | Williams Trevor Leigh | SVP, Manufacturing & Dist'n | award | 4,184 | $0.00 | — | 4,184 | Apr 30, 2026 |
| Apr 28, 2026 | Ahmed Javed | Director | award | 1,390 | $0.00 | — | 23,165 | Apr 30, 2026 |
| Apr 28, 2026 | Arzbaecher Robert C | Director | award | 1,390 | $0.00 | — | 54,304 | Apr 30, 2026 |
| Mar 17, 2026 | Mayer Erik M. | VP, Clean Energy & BusDevelop | open-market sale | 1,500 | $124.69 | $187K | 6,341 | Mar 19, 2026 |
| Mar 17, 2026 | Hoker Richard A | VP and Corporate Controller | open-market saleindirect | 3,499 | $125.38 | $439K | 31,036 | Mar 19, 2026 |
| Mar 17, 2026 | Frost Bert A | EVP, Chief Commercial Officer | open-market sale | 6,000 | $126.00 | $756K | 69,472 | Mar 19, 2026 |
| Mar 17, 2026 | Will W Anthony | Director | gift | 17,654 | $0.00 | — | 101,044 | Mar 17, 2026 |
| Mar 15, 2026 | Will W Anthony | Director | award | 96,858 | $0.00 | — | 118,698 | Mar 17, 2026 |
| Mar 15, 2026 | Will W Anthony | Director | disposition to issuer | 33,155 | $0.00 | — | 21,840 | Mar 17, 2026 |
| Mar 13, 2026 | Will W Anthony | Director | open-market sale | 20,368 | $131.17 | $3M | 54,995 | Mar 13, 2026 |
| Mar 13, 2026 | Will W Anthony | Director | open-market sale | 32,658 | $130.62 | $4M | 75,363 | Mar 13, 2026 |
| Mar 12, 2026 | Menzel Susan L | EVP and Chief Admin. Officer | open-market sale | 18,041 | $136.06 | $2M | 55,762 | Mar 13, 2026 |
| Mar 12, 2026 | Frost Bert A | EVP, Chief Commercial Officer | open-market sale | 6,250 | $136.69 | $854K | 75,472 | Mar 13, 2026 |
| Mar 11, 2026 | Will W Anthony | Director | open-market sale | 28,625 | $118.64 | $3M | 108,021 | Mar 13, 2026 |
| Mar 9, 2026 | Frost Bert A | EVP, Chief Commercial Officer | open-market sale10b5-1 | 5,534 | $116.21 | $643K | 81,722 | Mar 9, 2026 |
| Mar 6, 2026 | McGrane Michael Patrick | SVP, Gen. Counsel & Secretary | open-market sale | 3,666 | $116.50 | $427K | 19,161 | Mar 9, 2026 |
Full insider history for CF Industries Holding, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- CF INDUSTRIES HOLDINGS, INC., CIK 1324404 on EDGAR
- Extract generated
- November 1, 2026
- Withheld
- none
- Repaired
- none
XBRL concepts behind each line
Income statement
Revenues, SalesRevenueNetCostOfRevenueGrossProfitSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueShortTermInvestmentsAssetsCurrentAssetsLiabilitiesCurrentLongTermDebtNoncurrentStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationAndAmortization, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated November 1, 2026.
- JSON file
/data/financials/CF.json